Pliant Therapeutics Inc (PLRX)
Healthcare
Biotechnology
1.00 $
+0.0%
vs. previous close
Closing price · As of: 3. Aug 2026
Pliant Therapeutics Inc (PLRX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -128 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| -17 | -28 | -2.8 | -37 | -75 | -95 | -116 | -156 | -128 | |
| 0.3 | 0.7 | 1.1 | 1.3 | 1.5 | 1.8 | 1.8 | 2.1 | 1.7 | |
| 0.0 | 0.2 | 1.8 | 3.9 | 10 | 23 | 44 | 38 | 26 | |
| 0.0 | 0.2 | 1.8 | 4.2 | 10 | 23 | – | – | – | |
| 0.9 | 1.1 | -5.1 | -1.2 | 6.9 | 4.2 | 1.3 | 9.1 | -16 | |
| 1.4 | 2.3 | 1.0 | 1.5 | 2.0 | 1.8 | 0.9 | 3.8 | 0.4 | |
| -1.4 | -2.3 | -18 | -211 | 74 | -150 | -127 | 140 | 134 | |
| 0.0 | 87 | 48 | 213 | 2.5 | 216 | – | – | – | |
| – | – | 9.9 | 9.9 | 9.9 | 9.9 | 0.0 | 20 | -32 | |
| 20 | 87 | 46 | 213 | 2.5 | 227 | 274 | 23 | -32 | |
| 1.7 | 57 | 25 | -35 | 0.8 | -18 | 31 | 8.0 | -26 | |
| -18 | -31 | -3.7 | -39 | -77 | -96 | -117 | -159 | -129 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.